Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.98 USD | +1.02% | -7.04% | -34.22% |
May. 29 | Omega Therapeutics, Inc. Appoints Kaan Certel, Ph.D., as Chief Business Officer | CI |
May. 06 | Omega Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 4.45M | Sales 2025 * | 1.27M | Capitalization | 109M |
---|---|---|---|---|---|
Net income 2024 * | -77M | Net income 2025 * | -92M | EV / Sales 2024 * | -3.99 x |
Net cash position 2024 * | 127M | Net cash position 2025 * | 30.93M | EV / Sales 2025 * | 61.6 x |
P/E ratio 2024 * |
-1.57
x | P/E ratio 2025 * |
-1.63
x | Employees | 94 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.08% |
Latest transcript on Omega Therapeutics, Inc.
1 day | +1.02% | ||
1 week | -7.04% | ||
1 month | -11.21% | ||
3 months | -51.82% | ||
6 months | -13.54% | ||
Current year | -34.22% |
Managers | Title | Age | Since |
---|---|---|---|
Mahesh Karande
CEO | Chief Executive Officer | 51 | 19-05-31 |
Barbara Y. Chan
DFI | Director of Finance/CFO | 60 | - |
Samir Padalkar
CTO | Chief Tech/Sci/R&D Officer | - | 21-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Luke Beshar
BRD | Director/Board Member | 65 | 21-04-30 |
John Mendlein
BRD | Director/Board Member | 64 | 19-12-31 |
Christian Schade
CHM | Chairman | 63 | 23-07-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +3.86% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 1.98 | +1.02% | 388,707 |
24-05-30 | 1.96 | -1.01% | 368,894 |
24-05-29 | 1.98 | -6.16% | 434,339 |
24-05-28 | 2.11 | -0.94% | 459,595 |
24-05-24 | 2.13 | +0.47% | 540,008 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.22% | 109M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- OMGA Stock